secwatch / observer

8-K filed November 5, 2025, 6:59 PM ET ticker RXRX CIK 0001601830

leadership confidence high sentiment neutral materiality 0.80

Recursion appoints Najat Khan as CEO effective Jan 1, 2026; Q3 net loss $162.3M

RECURSION PHARMACEUTICALS, INC.

Najat Khan succeeds Chris Gibson as CEO and President effective Jan 1, 2026; Gibson becomes Chairman.
Khan's base salary set at $680K; receives $1M equity now and expected additional $7.5M equity.
Q3 revenue $5.2M (down from $26.1M); net loss $162.3M (vs $95.8M); R&D spend $121.1M.
Cash ~$785M as of Oct 9, 2025; runway through end-2027; raised $387.5M from ATM facility.
Second microglia phenomap accepted by Roche/Genentech triggers $30M milestone; total partner payments exceed $500M.

item 2.02 item 5.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001601830-25-000164
form_type: 8-K
ticker: RXRX
cik: 0001601830
company_name: RECURSION PHARMACEUTICALS, INC.
filed_at: 2025-11-05T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.884914+00:00
generated_at: 2026-05-17T00:17:55.118230+00:00
sec_items: ["2.02", "5.02", "7.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001601830-25-000164
json_url: https://secwatch.observer/filing/0001601830-25-000164.json
markdown_url: https://secwatch.observer/filing/0001601830-25-000164.md
text_url: https://secwatch.observer/filing/0001601830-25-000164.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000164/0001601830-25-000164-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000164/rxrx-20251104.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

CRVL

CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026

CORVEL CORP June 1, 2026, 5:05 PM ET leadership Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

Filing page SEC filing

WST

West Pharmaceutical appoints Michel Lagarde as CEO; Green retires, Friel becomes Chair

WEST PHARMACEUTICAL SERVICES INC June 1, 2026, 4:32 PM ET leadership Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

Filing page SEC filing

VRRM

Verra Mobility CEO David Roberts steps down amid cost realignment; interim CEO Keyser appointed

VERRA MOBILITY Corp June 1, 2026, 4:29 PM ET leadership Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

Filing page SEC filing

PENG

Penguin Solutions CFO Nate Olmstead to step down; Aaron Johnson named interim CFO; reaffirms FY2026 guidance at high end

Penguin Solutions, Inc. June 1, 2026, 4:17 PM ET leadership Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

Filing page SEC filing

NSC

Norfolk Southern COO John Orr resigns; Brian Barr appointed successor effective June 1

NORFOLK SOUTHERN CORP June 1, 2026, 9:15 AM ET leadership Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

Filing page SEC filing

ADTX

Aditxt names Jeffrey M. Busch Interim CEO; Amro Albanna steps down

Aditxt, Inc. June 1, 2026, 8:30 AM ET leadership Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

Filing page SEC filing

RPD

Rapid7 appoints Wael Mohamed CEO; Corey Thomas becomes Executive Chairman; reaffirms 2026 guidance

Rapid7, Inc. June 1, 2026, 8:29 AM ET leadership Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

Filing page SEC filing

CLX

Clorox CEO Linda Rendle steps down for health reasons; board initiates search

CLOROX CO /DE/ May 28, 2026, 4:05 PM ET leadership Items 5.02, 7.01, 9.01

same SEC item: 5.02, 7.01, 9.01 same event type: leadership similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001601830-25-000164

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.